Igor Dolgalev

Career Trajectory

Research Cluster Map

Direct collaborators. Node size = influence, colour = community, dashed = past collaboration.

• Table S2 from Blockade of IL1β and PD1 with Combination Chemotherapy Reduces Systemic Myeloid Suppression in Metastatic Pancreatic Cancer with Heterogeneous Effects in the Tumor

  2026-06-17

• Table S1 from Blockade of IL1β and PD1 with Combination Chemotherapy Reduces Systemic Myeloid Suppression in Metastatic Pancreatic Cancer with Heterogeneous Effects in the Tumor

  2026-06-17

• Figure S5 from Blockade of IL1β and PD1 with Combination Chemotherapy Reduces Systemic Myeloid Suppression in Metastatic Pancreatic Cancer with Heterogeneous Effects in the Tumor

  2026-06-17

• Figure S2 from Blockade of IL1β and PD1 with Combination Chemotherapy Reduces Systemic Myeloid Suppression in Metastatic Pancreatic Cancer with Heterogeneous Effects in the Tumor

  2026-06-17

• Table S3 from Blockade of IL1β and PD1 with Combination Chemotherapy Reduces Systemic Myeloid Suppression in Metastatic Pancreatic Cancer with Heterogeneous Effects in the Tumor

  2026-06-17

• Figure S1 from Blockade of IL1β and PD1 with Combination Chemotherapy Reduces Systemic Myeloid Suppression in Metastatic Pancreatic Cancer with Heterogeneous Effects in the Tumor

  2026-06-17

• Figure S4 from Blockade of IL1β and PD1 with Combination Chemotherapy Reduces Systemic Myeloid Suppression in Metastatic Pancreatic Cancer with Heterogeneous Effects in the Tumor

  2026-06-17

• Figure S7 from Blockade of IL1β and PD1 with Combination Chemotherapy Reduces Systemic Myeloid Suppression in Metastatic Pancreatic Cancer with Heterogeneous Effects in the Tumor

  2026-06-17

• Figure S6 from Blockade of IL1β and PD1 with Combination Chemotherapy Reduces Systemic Myeloid Suppression in Metastatic Pancreatic Cancer with Heterogeneous Effects in the Tumor

  2026-06-17

• Figure S3 from Blockade of IL1β and PD1 with Combination Chemotherapy Reduces Systemic Myeloid Suppression in Metastatic Pancreatic Cancer with Heterogeneous Effects in the Tumor

  2026-06-17

• MMP1 and PRSS23 induce PAR2 biased agonism in painful oral cancers

  Communications Biology · 2026-05-11

• Sa1901 THE EFFICACY OF ENDOSCOPIC ULTRASOUND GUIDED BIOPSIES TO SUCCESSFULLY GENERATE PATIENT DERIVED DOWNSTREAM PDAC MODELS FROM A SINGLE PROCEDURE

  Gastroenterology · 2026-05-01

• Sa1901 THE EFFICACY OF ENDOSCOPIC ULTRASOUND GUIDED BIOPSIES TO SUCCESSFULLY GENERATE PATIENT DERIVED DOWNSTREAM PDAC MODELS FROM A SINGLE PROCEDURE

  Gastrointestinal Endoscopy · 2026-05-01

• <b>A computational pipeline for the spatial analysis of immune cell interactions in lymphoid organs</b>

  Figshare · 2026-04-10

• <b>A computational pipeline for the spatial analysis of immune cell interactions in lymphoid organs</b>

  Figshare · 2026-04-10

• Transcription factor Etv3 controls the tolerogenic function of dendritic cells

  Science · 2026-02-12 · 2 citations

• Cohesin-mediated chromatin organization controls the differentiation and function of dendritic cells

  Science Immunology · 2026-02-06 · 4 citations

• Chromatin-mediated anticipatory control of type I interferon production in plasmacytoid dendritic cells

  Immunity · 2026-02-01 · 2 citations

• Duo-nano exosome encapsulating hydrogel boosts wound healing across xenogenic and allogenic models

  Biomaterials · 2026-01-03

• Duo-nano exosome encapsulating hydrogel boosts wound healing across xenogenic and allogenic models

  Biomaterials · 2025-12-27